Transcutaneous administration of dengue vaccines (2020)
- Authors:
- Santos, Robert Andreata
- Alves, Rubens Prince dos Santos
- Pereira, Sara Araujo
- Pereira, Lennon Ramos
- Freitas, Carla Longo de
- Pereira, Samuel Santo
- Carvalho, Alexia Adrianne Venceslau Brito
- Amarante, Maria Fernanda Castro
- Favaro, Marianna Teixeira de Pinho
- Santos, Camila Mathias dos
- Amorim, Jaime Henrique
- Ferreira, Luís Carlos de Souza
- Santos, Robert Andreata
- USP affiliated authors: FERREIRA, LUIS CARLOS DE SOUZA - ICB ; SANTOS, ROBERT ANDREATA - ICB ; ALVES, RÚBENS PRINCE DOS SANTOS - ICB ; PEREIRA, LENNON RAMOS - ICB ; PEREIRA, SAMUEL SANTOS - ICB ; CARVALHO, ALEXIA ADRIANNE VENCESLAU BRITO - ICB ; AMARANTE, MARIA FERNANDA DE CASTRO - ICB ; FAVARO, MARIANNA TEIXEIRA DE PINHO - ICB
- Unidade: ICB
- DOI: 10.3390/v12050514
- Subjects: MICROBIOLOGIA; DENGUE; VÍRUS DA DENGUE; ADJUVANTES IMUNOLÓGICOS; VACINAS VIRAIS; CAMUNDONGOS; TOXINAS EM ANIMAL; IMUNIZAÇÃO; IMUNOGLOBULINAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SANTOS, Robert Andreata et al. Transcutaneous administration of dengue vaccines. Viruses, v. 12, n. 5, p. 16 , 2020Tradução . . Disponível em: https://doi.org/10.3390/v12050514. Acesso em: 12 fev. 2026. -
APA
Santos, R. A., Alves, R. P. dos S., Pereira, S. A., Pereira, L. R., Freitas, C. L. de, Pereira, S. S., et al. (2020). Transcutaneous administration of dengue vaccines. Viruses, 12( 5), 16 . doi:10.3390/v12050514 -
NLM
Santos RA, Alves RP dos S, Pereira SA, Pereira LR, Freitas CL de, Pereira SS, Carvalho AAVB, Amarante MFC, Favaro MT de P, Santos CM dos, Amorim JH, Ferreira LC de S. Transcutaneous administration of dengue vaccines [Internet]. Viruses. 2020 ; 12( 5): 16 .[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/v12050514 -
Vancouver
Santos RA, Alves RP dos S, Pereira SA, Pereira LR, Freitas CL de, Pereira SS, Carvalho AAVB, Amarante MFC, Favaro MT de P, Santos CM dos, Amorim JH, Ferreira LC de S. Transcutaneous administration of dengue vaccines [Internet]. Viruses. 2020 ; 12( 5): 16 .[citado 2026 fev. 12 ] Available from: https://doi.org/10.3390/v12050514 - Enhanced immune responses and protective immunity to Zika vrus induced by a DNA vaccine encoding a chimeric NS1 fused wth tpe 1 Herpes vrus gD protein
- Anti-Flavivirus vaccines: review of the present situation and perspectives of subunit vaccines produced in Escherichia coli
- Nanovaccine based on self-assembling nonstructural protein 1 boosts antibody responses to Zika virus
- The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variant
- The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo
- Protective immunity to Dengue virus induced by DNA vaccines encoding nonstructural proteins in a lethal challenge immunocompetent mouse model
- Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1
- Specificity of NS1-based immunochromatographic tests for dengue virus with regard to the Zika virus protein
- Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview
- Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies
Informações sobre o DOI: 10.3390/v12050514 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Transcutaneous administra... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
